Cargando…

Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis

BACKGROUND: Oral anticoagulation is recommended for stroke prevention in intermediate/high stroke risk atrial fibrillation (AF) patients. The objective of this study was to demonstrate the usefulness of analytic software tools for descriptive analyses of disease management in atrial AF; a secondary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Kathleen, Bozkaya, Duygu, Patel, Aarti A, Macomson, Brian, Nelson, Winnie, Owens, Gary, Mody, Samir, Schein, Jeff, Menzin, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126814/ https://www.ncbi.nlm.nih.gov/pubmed/25069459 http://dx.doi.org/10.1186/1472-6963-14-329

Ejemplares similares

Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis
por: Lang, Kathleen, et al.
Publicado: (2014)

Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed
por: Crivera, Concetta, et al.
Publicado: (2016)

Gastrointestinal comorbidities associated with atrial fibrillation
por: Laliberté, François, et al.
Publicado: (2014)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2015)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
por: Nelson, Winnie W., et al.
Publicado: (2014)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021)

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
por: Silva, Rose Mary Ferreira Lisboa Da, et al.
Publicado: (2019)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion
por: Barysienė, Jūratė, et al.
Publicado: (2017)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Impact of Atrial Fibrillation on Stroke‐Related Healthcare Costs
por: Sussman, Matthew, et al.
Publicado: (2013)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome
por: Chen, Shih-Yin, et al.
Publicado: (2014)

Nurses’ self-reported time estimation of anticoagulation therapy: a survey of warfarin management in long-term care
por: Patel, Aarti A, et al.
Publicado: (2015)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
por: Sholzberg, Michelle, et al.
Publicado: (2016)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
por: Poposka, Lidija, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_740cjsj5o7jrbvp0eg91g8ft8a